← Leaderboards
Inder Mohan Verma
Salk Institute For Biological Studies
$21,447,349
Attributed
$21,447,349
Total exposure
20
Grants
12
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $3.9M · FY2005–19$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
Funding mix
By agency
NIH$35,526,617 · 21
By mechanism
P01$14,197,090 · 3
R01$12,356,781 · 3
R37$7,338,250 · 1
R35$1,229,331 · 1
P30$236,855 · 3
P41$90,810 · 5
Top collaborators
No co-investigators on record.
Most similar at Salk Institute For Biological Studies
Same institution · by research overlap
- Dennis D O'Leary$25,408,742
- Samuel L. Pfaff$22,717,205
- Greg E Lemke$21,131,063
- Tony R. Hunter$71,438,544
- Clodagh O'Shea$8,849,066
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsMouse ModelGene TherapyMalignant NeoplasmsTumorGenesGenerationsVectorMolecularNeuronsPathway InteractionsAffectLentivirus VectorIn VitroGene TargetingViral VectorCell Growth RegulationGlioblastomaLaboratory MouseGliomaBrainTissuesCell TypeAnimals
Grant awards (59)
Shared Resource-Viral Vector Core$93,730
P30 · FY2019 · CA · contact PI
Molecular Mechanisms and Therapeutic Approaches to Malignant Gliomas$671,581
R01 · FY2017 · CA · contact PI
Molecular Mechanisms and Therapeutic Approaches to Malignant Gliomas$671,581
R01 · FY2016 · CA · contact PI
Regulation of NF-Kappa B$714,981
R01 · FY2014 · AI · contact PI
Lentiviral Vectors to Model Human Gliomas in Mice$652,800
R01 · FY2014 · HL · contact PI
Regulation of NF-Kappa B$672,082
R01 · FY2013 · AI · contact PI
Lentiviral Vectors to Model Human Gliomas in Mice$634,146
R01 · FY2013 · HL · contact PI
Mouse Models and Cancer Stem Cells$22,045
P30 · FY2013 · CA · contact PI
Regulation of NF-Kappa B$714,981
R01 · FY2012 · AI · contact PI
Lentiviral Vectors to Model Human Gliomas in Mice$666,121
R01 · FY2012 · HL · contact PI
Mouse Models and Cancer Stem Cells$23,578
P30 · FY2012 · CA · contact PI
Regulation of NF-Kappa B$715,263
R01 · FY2011 · AI · contact PI
Lentiviral Vectors to Model Human Gliomas in Mice$687,125
R01 · FY2011 · HL · contact PI
MULTISCALE CHARACTERIZATION OF VIRAL VECTOR-INDUCED GLIOBLASTOMAS$24,666
P41 · FY2011 · RR · contact PI
Mouse Models and Cancer Stem Cells$23,577
P30 · FY2011 · CA · contact PI
Regulation of NF-Kappa B$745,119
R01 · FY2010 · AI · contact PI
Viral Vectors$117,822
P01 · FY2010 · AG · contact PI
Mouse Models and Cancer Stem Cells$24,818
P30 · FY2010 · CA · contact PI
MULTISCALE CHARACTERIZATION OF VIRAL VECTOR-INDUCED GLIOBLASTOMAS$19,125
P41 · FY2010 · RR · contact PI
REGULATION OF NF-KAPPA B$817,698
R37 · FY2009 · AI · contact PI
Mouse Models and Cancer Stem Cells$25,729
P30 · FY2009 · CA · contact PI
MULTISCALE CHARACTERIZATION OF VIRAL VECTOR-INDUCED GLIOBLASTOMAS$24,935
P41 · FY2009 · RR · contact PI
REGULATION OF NF-KAPPA B$811,614
R37 · FY2008 · AI · contact PI
Lentiviral Vectors for Gene Transfer$635,999
R01 · FY2008 · HL · contact PI
MULTISCALE CHARACTERIZATION OF VIRAL VECTOR-INDUCED GLIOBLASTOMAS$15,610
P41 · FY2008 · RR · contact PI
REGULATION OF NF-KAPPA B$831,783
R37 · FY2007 · AI · contact PI
Lentiviral Vectors for Gene Transfer$634,206
R01 · FY2007 · HL · contact PI
REGULATION OF NF-KAPPA B$836,199
R37 · FY2006 · AI · contact PI
Lentiviral Vectors for Gene Transfer$638,372
R01 · FY2006 · HL · contact PI
IDENTIFICATION OF IKK SIGNALING TARGETS$2,859
P41 · FY2006 · RR · contact PI
Transcriptional Regulation of Cell Growth$2,553,083
P01 · FY2005 · CA
REGULATION OF NF-KAPPA B$734,859
R37 · FY2005 · AI
Lentiviral Vectors for Gene Transfer$648,642
R01 · FY2005 · HL
Transcriptional Regulation of Cell Growth$2,481,428
P01 · FY2004 · CA
REGULATION OF NF-KAPPA B$729,137
R37 · FY2004 · AI
Program Leader$23,378
P30 · FY2004 · CA
IDENTIFICATION OF IKK SIGNALING TARGETS$3,615
P41 · FY2004 · RR
Transcriptional Regulation of Cell Growth$2,411,844
P01 · FY2003 · CA
REGULATION OF NF-KAPPA B$707,780
R37 · FY2003 · AI
GENE THERAPY FOR HEMOPHILIA A AND B$571,120
R01 · FY2003 · HL
Transcriptional Regulation of Cell Growth$2,344,299
P01 · FY2002 · CA
GENE THERAPY FOR HEMOPHILIA A AND B$580,809
R01 · FY2002 · HL
REGULATION OF NF-KAPPA B$572,152
R37 · FY2002 · AI
NHF Fifth Workshop on Gene Therapies for Hemophilia$10,000
R13 · FY2002 · HL
MOLECULAR ANALYSIS OF LFG$0
P01 · FY2002 · CA
Transcriptional Regulation of Cell Growth$2,233,611
P01 · FY2001 · CA
REGULATION OF NF-KAPPA B$630,062
R37 · FY2001 · AI
GENE THERAPY FOR HEMOPHILIA A AND B$563,316
R01 · FY2001 · HL
4th Annual Meeting, American Society of Gene Therapy$32,500
R13 · FY2001 · HL
2001 Workshop on Gene Therapies for Hemophilia$10,000
R13 · FY2001 · HL
MOLECULAR ANALYSIS OF LFG$0
P01 · FY2001 · CA
TRANSCRIPTIONAL REGULATION OF CELL GROWTH$1,983,606
P01 · FY2000 · CA
ONCOGENES, PROTO-ONCOGENES AND RETROVIRAL VECTORS$1,229,331
R35 · FY2000 · CA
REGULATION OF NF-KAPPA B$666,966
R37 · FY2000 · AI
GENE THERAPY FOR HEMOPHILIA A AND B$538,537
R01 · FY2000 · HL
TRANSCRIPTIONAL REGULATION OF CELL GROWTH$48,646
P01 · FY2000 · CA
TRANSCRIPTIONAL REGULATION OF CELL GROWTH$22,751
P01 · FY2000 · CA
THIRD WORKSHOP ON GENE THERAPIES FOR HEMOPHILIA$15,000
R13 · FY2000 · HL
GENE THERAPY--THE NEXT MILLENNIUM$10,000
R13 · FY2000 · DK